documents: EPA-HQ-OPP-2012-0565-0059
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-HQ-OPP-2012-0565-0059 | EPA | EPA-HQ-OPP-2012-0565 | Norflurazon: Responses to Additional Comments on the “Draft Human Health Risk Assessment in Support of Registration Review, D432685” Regarding Dermal Studies (June 12, 2019) | Supporting & Related Material | Comment Response | 2022-12-23T05:00:00Z | 2022 | 12 | 2022-12-24T01:48:32Z | 0 | 0 | 0900006485547dab |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref